These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 31666337)

  • 1. Modified sites and functional consequences of 4-oxo-2-nonenal adducts in HDL that are elevated in familial hypercholesterolemia.
    May-Zhang LS; Yermalitsky V; Melchior JT; Morris J; Tallman KA; Borja MS; Pleasent T; Amarnath V; Song W; Yancey PG; Davidson WS; Linton MF; Davies SS
    J Biol Chem; 2019 Dec; 294(50):19022-19033. PubMed ID: 31666337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification by isolevuglandins, highly reactive γ-ketoaldehydes, deleteriously alters high-density lipoprotein structure and function.
    May-Zhang LS; Yermalitsky V; Huang J; Pleasent T; Borja MS; Oda MN; Jerome WG; Yancey PG; Linton MF; Davies SS
    J Biol Chem; 2018 Jun; 293(24):9176-9187. PubMed ID: 29712723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modifying apolipoprotein A-I by malondialdehyde, but not by an array of other reactive carbonyls, blocks cholesterol efflux by the ABCA1 pathway.
    Shao B; Pennathur S; Pagani I; Oda MN; Witztum JL; Oram JF; Heinecke JW
    J Biol Chem; 2010 Jun; 285(24):18473-84. PubMed ID: 20378541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactive Dicarbonyl Scavenging Effectively Reduces MPO-Mediated Oxidation of HDL and Restores PON1 Activity.
    Huang J; Yancey PG; Tao H; Borja MS; Smith LE; Kon V; Davies SS; Linton MF
    Nutrients; 2020 Jun; 12(7):. PubMed ID: 32629758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-linking modifications of HDL apoproteins by oxidized phospholipids: structural characterization,
    Gao D; Ashraf MZ; Zhang L; Kar N; Byzova TV; Podrez EA
    J Biol Chem; 2020 Feb; 295(7):1973-1984. PubMed ID: 31907281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
    Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
    Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scavenging dicarbonyls with 5'-O-pentyl-pyridoxamine increases HDL net cholesterol efflux capacity and attenuates atherosclerosis and insulin resistance.
    Huang J; Tao H; Yancey PG; Leuthner Z; May-Zhang LS; Jung JY; Zhang Y; Ding L; Amarnath V; Liu D; Collins S; Davies SS; Linton MF
    Mol Metab; 2023 Jan; 67():101651. PubMed ID: 36481344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysine glycation of apolipoprotein A-I impairs its anti-inflammatory function in type 2 diabetes mellitus.
    Liu D; Ji L; Zhao M; Wang Y; Guo Y; Li L; Zhang D; Xu L; Pan B; Su J; Xiang S; Pennathur S; Li J; Gao J; Liu P; Willard B; Zheng L
    J Mol Cell Cardiol; 2018 Sep; 122():47-57. PubMed ID: 30092227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scavenging of reactive dicarbonyls with 2-hydroxybenzylamine reduces atherosclerosis in hypercholesterolemic Ldlr
    Tao H; Huang J; Yancey PG; Yermalitsky V; Blakemore JL; Zhang Y; Ding L; Zagol-Ikapitte I; Ye F; Amarnath V; Boutaud O; Oates JA; Roberts LJ; Davies SS; Linton MF
    Nat Commun; 2020 Aug; 11(1):4084. PubMed ID: 32796843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acrolein impairs ATP binding cassette transporter A1-dependent cholesterol export from cells through site-specific modification of apolipoprotein A-I.
    Shao B; Fu X; McDonald TO; Green PS; Uchida K; O'Brien KD; Oram JF; Heinecke JW
    J Biol Chem; 2005 Oct; 280(43):36386-96. PubMed ID: 16126721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein A-I kinetics in heterozygous familial hypercholesterolemia: a stable isotope study.
    Frénais R; Ouguerram K; Maugeais C; Marchini JS; Benlian P; Bard JM; Magot T; Krempf M
    J Lipid Res; 1999 Aug; 40(8):1506-11. PubMed ID: 10428988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site-specific oxidation of apolipoprotein A-I impairs cholesterol export by ABCA1, a key cardioprotective function of HDL.
    Shao B
    Biochim Biophys Acta; 2012 Mar; 1821(3):490-501. PubMed ID: 22178192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice.
    Navab M; Anantharamaiah GM; Reddy ST; Hama S; Hough G; Grijalva VR; Wagner AC; Frank JS; Datta G; Garber D; Fogelman AM
    Circulation; 2004 Jun; 109(25):3215-20. PubMed ID: 15197147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arg123-Tyr166 domain of human ApoA-I is critical for HDL-mediated inhibition of macrophage homing and early atherosclerosis in mice.
    Holvoet P; Peeters K; Lund-Katz S; Mertens A; Verhamme P; Quarck R; Stengel D; Lox M; Deridder E; Bernar H; Nickel M; Theilmeier G; Ninio E; Phillips MC
    Arterioscler Thromb Vasc Biol; 2001 Dec; 21(12):1977-83. PubMed ID: 11742873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of covalent modifications of HDL apoproteins by endogenous oxidized phospholipids.
    Gao D; Podrez EA
    Free Radic Biol Med; 2018 Feb; 115():57-67. PubMed ID: 29155052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein adducts generated from products of lipid oxidation: focus on HNE and one.
    Sayre LM; Lin D; Yuan Q; Zhu X; Tang X
    Drug Metab Rev; 2006; 38(4):651-75. PubMed ID: 17145694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-density lipoprotein-associated sphingosine-1-phosphate activity in heterozygous familial hypercholesterolaemia.
    Frias MA; Thomas A; Brulhart-Meynet MC; Kövamees O; Pernow J; Eriksson M; Angelin B; James RW; Brinck JW
    Eur J Clin Invest; 2017 Jan; 47(1):38-43. PubMed ID: 27861771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinase 8 degrades apolipoprotein A-I and reduces its cholesterol efflux capacity.
    Salminen A; Åström P; Metso J; Soliymani R; Salo T; Jauhiainen M; Pussinen PJ; Sorsa T
    FASEB J; 2015 Apr; 29(4):1435-45. PubMed ID: 25550459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CER-001, a HDL-mimetic, stimulates the reverse lipid transport and atherosclerosis regression in high cholesterol diet-fed LDL-receptor deficient mice.
    Tardy C; Goffinet M; Boubekeur N; Ackermann R; Sy G; Bluteau A; Cholez G; Keyserling C; Lalwani N; Paolini JF; Dasseux JL; Barbaras R; Baron R
    Atherosclerosis; 2014 Jan; 232(1):110-8. PubMed ID: 24401224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein A-I glycation by glucose and reactive aldehydes alters phospholipid affinity but not cholesterol export from lipid-laden macrophages.
    Brown BE; Nobecourt E; Zeng J; Jenkins AJ; Rye KA; Davies MJ
    PLoS One; 2013; 8(5):e65430. PubMed ID: 23741493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.